Business Day (Nigeria)

Moji Adeyeye giving NAFDAC new lease of life

- ANTHONIA OBOKOH

Since taking over the helms of affairs as the directorge­neral of the National Agency for Food and Drug Administra­tion and Control ( NAFDAC), Moji Adeyeye – a pharmacist and professor has given the regulatory agency a new lease of life.

Moji who became the DG on November 3, 2017, has sharpened the agency focus on increasing access to quality and efficaciou­s medicines through local manufactur­ing.

Some of the successes in this area include the developmen­t of guidelines for Active Pharmaceut­ical Ingredient ( API). The Agency, through the support of its developmen­t partners the United States for Internatio­nal Developmen­t ( USAID) and United States Pharmacope­ia (USP)], carried out assessment­s of 165 local Pharmaceut­ical Manufactur­ers in Nigeria with a view to developing a Good Manufactur­ing Practice ( GMP) Roadmap for NAFDAC and the pharmaceut­ical industry.

It is gratifying to see several multi-national Pharma forming partnershi­ps with local companies as a result of strengthen­ing of the local companies. Local manufactur­ing will improve drug security, reduce SFS, improve the GDP, and reduce unemployme­nt.

As a result of the Agency- wide training in QMS, NAFDAC was ISO 9001:2015 Certified in June 2019. The agency is also encouragin­g the Pharmaceut­ical Industry to imbibe similar quality management systems in their operations through training and capacity building.

“The WHO Benchmarki­ng Programme commenced in Nigeria in January 2018 and since then we have imbibed a culture of self - audit as part of Who-global Benchmarki­ng requiremen­ts and in line with Internatio­nal Best Practices. We have continued to improve our maturity level since the first WHO Audit in June 2019. Currently, we are working towards attaining Maturity Level 3 to enable the production of vaccines in the country,” the DG said.

“The ultimate goal, however, is to achieve Maturity Level 4, which will make Pharmaceut­ical Companies in Nigeria attain WHO Prequalifi­cation.”

To enhance local production of pharmaceut­icals in Nigeria, the Agency reviewed and updated its Five Plus Five-year Validity policy. A product registrati­on license is valid for 5 years and by the end of the 4th year of license validity, companies are required to submit draft blueprints of proposed partnershi­ps with Nigerian companies or/and set up local manufactur­ing plant.

Upon successful renewal for another 5 years for companies with verifiable blueprints, NAFDAC will monitor the migration of the imported drugs to local production. At the end of Year 7 (First 5 years + 2 years into renewal) if there is no progress on migration to local manufactur­ing as detailed in the blueprint, an alert for de-registrati­on will be sent to the company at the beginning of ninth year.

Adeyeye further said that special attention is now being given the Micro Small and Medium Enterprise­s MSMES by the Agency through proffering possible solutions to the teething problems associated with registrati­on and securing approval for locally manufactur­ed products.

“NAFDAC is now in partnershi­p with private sectordriv­en bodies like Lagos Chamber of Commerce and Industry (LCCI), National Associatio­n of Chambers of Commerce and Industry, Mines and Agricultur­e (NACCIMA) to create public awareness leveraging on the bodies’ sectoral event platforms.

“NAFDAC, being an active member of the Presidenti­al Enabling Environmen­t Council (PEBEC), has continued to support the job creation agenda of the present administra­tion inline with the provisions of Executive Order No. 001,” she added.

The Agency has carried out a lot of reforms of its activities to create an enabling environmen­t for MSMES businesses to thrive, focusing on micro and small companies.

According to Adeyeye however, the Agency ensures that only quality products that are safe, efficaciou­s, and wholesome reach the market and ultimately, the consuming public.

She has enhanced the processing of all NAFDAC licenses (Approvals, Certificat­es, and Permits) to ensure efficiency and eliminatio­n of person to person contact, leading to the availabili­ty of end-to-end online automated processing platforms with outputs being digitized electronic licenses.

To further encourage the sector, on the 15th May 2020, NAFDAC launched the assisted registrati­on through NAFDAC Automated Product Administra­tion and Monitoring System (NAPAMS) for MSMES as a means in easing their registrati­on processes. The launch ran concurrent­ly in the six geo-political zones plus FCT and Lagos state.

It is worthy to state here that during this COVID 19 Pandemic; the Agency instituted the following palliative programs for micro and small enterprise­s (MSES): Zero tariffs for first 200 MSES, within a time lag; 80 percent reduction in tariffs for registrati­on of MSES products for a period of 6 months; waivers on administra­tive charges for renewal of expired licenses for products of MSES for the same period.

Ad e y e y said that the Agency remained functional even during the COVID-19 pandemic, though it activated alternativ­e pathways to ensure that GMP Inspection­s continue, neverthele­ss.

 ??  ??

Newspapers in English

Newspapers from Nigeria